FDA Inspection 1021316 — Alina S. Agafina
The FDA completed an inspection of Alina S. Agafina on July 14, 2017 in St. Petersburg. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Drugs.
Inspection Details
- Classification
- No Action Indicated (NAI) (NAI)
- End Date
- July 14, 2017
- Fiscal Year
- 2017
- Product Type
- Drugs
- Project Area
- Bioresearch Monitoring
- Location
- St. Petersburg (Russia)
Additional Details
Clinical Investigator (CI)